RESUMO
The effect of a high-fat meal on the absorption and pharmacokinetics of 17 beta-estradiol (E2), estrone (E1), estrone sulfate (E1S), and 17-deacetylnorgestimate (17d-NGM) were determined in this two-way complete crossover study of a single dose of E2/NGM (2 mg/180 micrograms) in 24 postmenopausal women. Equal numbers of subjects were randomly assigned to two treatment sequences indicated by the order of fed and fasting treatments. Serial blood samples were collected before and after dosing and assayed using validated methods. Food had no effect on the pharmacokinetics of E2, the pharmacologically active estrogen species. Food increased the rates of formation of E1 and E1S and slowed the formation of 17d-NGM. However, because E1 and E1S are pharmacologically less active metabolites of E2, and since the pharmacokinetic alterations in 17d-NGM were observed over a short time period, these results are probably of no clinical relevance. The extent of formation of all analytes, as measured by AUC, was not affected by food. In conclusion, administration of a tablet containing 17 beta-estradiol/norgestimate (2 mg/180 micrograms) was safe and well tolerated by healthy postmenopausal women and may be given without regard to the timing of meals in relation to dosing.
Assuntos
Gorduras na Dieta/metabolismo , Estradiol/farmacocinética , Interações Alimento-Droga , Norgestrel/análogos & derivados , Norgestrel/farmacocinética , Pós-Menopausa/metabolismo , Disponibilidade Biológica , Anticoncepcionais Orais Sintéticos/efeitos adversos , Anticoncepcionais Orais Sintéticos/farmacocinética , Estudos Cross-Over , Estradiol/efeitos adversos , Feminino , Humanos , Pessoa de Meia-Idade , Norgestrel/efeitos adversos , Saúde da MulherRESUMO
A sample of 943 adolescents from the general population were questioned about sleep problems. A quarter of the sample reported needing a lot more sleep than they previously had, and 10% of the sample complained of difficulty falling asleep. Adolescents reporting sleep problems showed more anxious, depressed, inattentive, and conduct disorder behaviors than those who had no (or only occasional) sleep problems. Sleep problems, particularly multiple problems, were associated with DSM-III disorder. There were no significant differences between male and female adolescents on any of the above measures. Finally, sleep problems were relatively persistent over time from ages 13 to 15.